or Try an Advanced Search...

    Hematological Cancers Stocks List

    Symbol Grade Name % Change
    ELTX B Elicio Therapeutics, Inc. -1.87
    ARGX B argenx SE 0.95
    HCM F Hutchison China MediTech Limited -4.83
    CRIS F Curis, Inc. 5.20
    BLRX F BioLineRx Ltd. -1.24
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Major
    Related Stock Lists: Cancer Drug Discovery Solid Tumors Acute Myeloid Leukemia Autoimmune Disease Biotechnology Clinical Trial Lymphoma Non Small Cell Lung Cancer Small Cell Lung Cancer Treatment Of Hematological Cancers Advanced Non Small Cell Lung Cancer Anaplastic Lymphoma Kinase Beauty Care Products Beverage Biology Biopharmaceutical Biopharmaceutical Development Breast Cancer Cancer Cell

    Related ETFs - A few ETFs which own one or more of the above listed Hematological Cancers stocks.

    Symbol Grade Name Weight
    BBH D Market Vectors Biotech ETF 5.75
    MNTL D Tema Neuroscience and Mental Health ETF 5.59
    BMED A BlackRock Future Health ETF 3.78
    FMED A Fidelity Disruptive Medicine ETF 3.69
    FBT A First Trust Amex Biotech Index Fund 3.23
    View all Hematological Cancers ETFs...
    Compare ETFs
    Compare BMED to FBT Compare MNTL to BMED Compare MNTL to FBT

        Hematological Cancers Stocks Recent News

        Date Stock Title
        Jan 23 ARGX argenx: Lofty Valuation Diminishes Appeal Amid Autoimmune Expansion (Rating Downgrade)
        Jan 23 ARGX Is argenx SE (ARGX) the High Growth International Stock to Invest in Now?
        Jan 23 ARGX Is Ascendis Pharma (ASND) the High Growth International Stock to Invest in Now?
        Jan 21 BLRX BioLineRx Issues Letter to Shareholders
        Jan 21 ELTX Why INNOVATE Shares Are Trading Higher By Over 19%; Here Are 20 Stocks Moving Premarket
        Jan 17 ARGX Argenx cut to Sell at Deutsche Bank on valuation
        Jan 17 BLRX Nasdaq Surges Over 300 Points; State Street Earnings Top Views
        Jan 17 ARGX Earnings Estimates Rising for Argenx (ARGX): Will It Gain?
        Jan 17 BLRX S&P 500 Gains 1%; Fastenal Posts Downbeat Earnings
        Jan 17 BLRX BioLineRx announces change to ratio of ADS to ordinary shares
        Jan 17 BLRX BioLineRx Announces Change to Ratio of American Depositary Shares to Ordinary Shares
        Jan 17 ELTX Why Versus Systems Shares Are Trading Higher By Around 71%; Here Are 20 Stocks Moving Premarket
        Related Industries: Biotechnology Drug Manufacturers - Major
        Related Stock Lists: Cancer Drug Discovery Solid Tumors Acute Myeloid Leukemia Autoimmune Disease Biotechnology Clinical Trial Lymphoma Non Small Cell Lung Cancer Small Cell Lung Cancer Treatment Of Hematological Cancers Advanced Non Small Cell Lung Cancer Anaplastic Lymphoma Kinase Beauty Care Products Beverage Biology Biopharmaceutical Biopharmaceutical Development Breast Cancer Cancer Cell
        Hematological Cancers

        Hematological cancers are cancers that affect the blood, bone marrow, and lymphatic system. Examples of hematological cancers include leukemia, lymphoma, and multiple myeloma. These cancers are caused by abnormal growth of cells in the blood or bone marrow, which can lead to the production of abnormal or immature cells. Treatment for hematological cancers may include chemotherapy, radiation therapy, stem cell transplant, and targeted therapy.

        Browse All Tags